In my previous article, I made three important arguments about leaders’ efforts and responsibility to enhance the justice, equity, diversity and inclusion (JEDI) of their work and impact in their ...

For decades, biopharma executives have seen operational costs and complexities soar. As commercial pricing, reimbursement, and market access hurdles remain particularly difficult to overcome, CEOs are ...

Forbes contributors publish independent expert analyses and insights. I am a behavioral statistician sharing my research in leadership development. Hand holding magnifier glass to searching red human ...

The global life sciences firm, a wholly owned subsidiary of Japan-based JSR Corporation, said it plans to have its ...